Cystic Fibrosis – Opportunity Analysis and Forecasts to 2025
Wednesday, July 11, 2018
Global (7MM) sales for the cystic fibrosis (CF) market are forecast by GlobalData to grow from $2.1B in 2015 to $7.6B in 2025. The majority of sales are expected to come from the US, which will represent 68% of the market by 2025. The sales growth during the 2015–2025 forecast periods will be primarily driven by the launches of Vertex’s cystic fibrosis transmembrane conductance regulator (CFTR) modulator ivacaftor/tezacaftor.